Zobrazeno 31 - 40
of 61
pro vyhledávání: '"Tiancheng Xie"'
Publikováno v:
IEEE Symposium on Security and Privacy
We present a new succinct zero knowledge argument scheme for layered arithmetic circuits without trusted setup. The prover time is O(C + nlogn) and the proof size is O(D logC +log2 n) for a D-depth circuit with n inputs and C gates. The verification
Autor:
Matthew K. Ball, Jose C. Villasboas, Aaron S. Mansfield, Xin Liu, Benjamin J. Madden, Roxana S. Dronca, Bharath Wootla, Jacob J. Orme, M. Cristine Charlesworth, Tiancheng Xie, Yanli Li, Fabrice Lucien, Susan M. Harrington, Haidong Dong, Tariq U. Azam, Khalid Jazieh
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
ADAM10 and ADAM17 expression and soluble PD-L1 (sPD-L1) predict poor prognosis in many malignancies, including in patients treated with PD-(L)1 inhibitors. The mechanism of soluble PD-L1 production and its effects are unknown. Here we uncover a novel
Autor:
Hongyan Liu, Tiancheng Xie
Publikováno v:
Arabian Journal of Geosciences. 13
The rock mass contains the macroscopic and mesoscopic flaws at the same time, and therefore, how to accurately assess their co-effect on the rock mass mechanical behavior is still an important and difficult issue. The elastic-brittle model and Null m
Publikováno v:
European Journal of Clinical Pharmacology. 74:723-729
We intend to investigate the association between tacrolimus-induced new-onset diabetes after transplantation (NODAT) and polymorphisms of CYP3A4, CYP3A5, ATP-binding cassette transporter sub-family C member 8 (ABCC8), and glucokinase (GCK) in renal t
Autor:
Guanghui Hu, Bisheng Huang, Chi Huang, Xiaolu Zhang, Mengnan Liu, Saiyang Li, Tiancheng Xie, Jingwei Zhang, Yunfei Xu
Publikováno v:
Oncology Reports. 38:2935-2940
The leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) is highly expressed in many human malignancies and is correlated with poor prognosis. However, the function of LETM1 in bladder cancer still remains unknown. In the present study,
Autor:
TIANCHENG XIE1, GUANGHUI HU1, BINBIN DONG1, YANGYE YAN1, MIN LIU1, XUDONG YAO1, JUNHUA ZHENG1, YUNFEI XU1 xuyunfeibb@sina.com
Publikováno v:
Experimental & Therapeutic Medicine. May2017, Vol. 13 Issue 5, p2169-2176. 8p.
Publikováno v:
Urology Journal. Nov/Dec2016, Vol. 13 Issue 6, p2889-2892. 4p.
Autor:
Guanghui Hu, Wei Zhai, Jingwei Zhang, Tiancheng Xie, Xudong Yao, Junhua Zheng, Jian-Ping Che, Bisheng Huang, Chi Huang, Yunfei Xu, Binbin Dong
Publikováno v:
Oncotarget
// Guanghui Hu 1 * , Binbin Dong 2, * , Jingwei Zhang 1, * , Wei Zhai 1, 3 , Tiancheng Xie 1 , Bisheng Huang 1 , Chi Huang 4 , Xudong Yao 1 , Junhua Zheng 1 , Jianping Che 1, 4 and Yun-Fei Xu 1 1 Department of Urology, Shanghai Tenth People’s Hospi
Autor:
Binbin Dong, Guanghui Hu, Tiancheng Xie, Yunfei Xu, Yangye Yan, Min Liu, Xudong Yao, Junhua Zheng
Publikováno v:
Experimental and Therapeutic Medicine
Roscovitine is a cyclin-dependent kinase inhibitor, which has been previously investigated for its anticancer effects. It has also been confirmed that roscovitine can downregulate the expression of myeloid cell leukemia-1 protein to inhibit inflammat
Autor:
Haidong Dong, Tiancheng Xie, Chunhua Chen, Liewei Wang, Xin Liu, Siyu Cao, Eugene D. Kwon, Yiyi Yan, Yanli Li, Xiaosheng Wu, Aaron S. Mansfield, Susan M. Harrington, Kun Ling, Tu Pham
Publikováno v:
Heliyon, Vol 5, Iss 3, Pp e01309-(2019)
Heliyon
Heliyon
Development of resistance to chemotherapy is a major obstacle in extending the survival of patients with cancer. Although originally defined as an immune checkpoint molecule, B7-H1 (also named as PD-L1 or CD274) was found to play a role in cancer che